Search

The service provides Lindus' recruitment and operational support along with the CRO's digital trial management platform, Citrus. [ABSTRACT FROM AUTHOR]

Ina Zschocke will lead European operations and oversee business growth on the continent as Innovaderm looks to improve efficiency and client service. [ABSTRACT FROM AUTHOR]

Syneos Health has tapped IQVIA's Costa Panagos to take the reins from former CEO Colin Shannon. [ABSTRACT FROM AUTHOR]

Lilly initially launched the Life Sciences Studio to expand their research footprint in San Diego, but with the sale the lab's automation platform has been moved to Oxford. [ABSTRACT FROM AUTHOR]

Charles River has about 21,400 workers across more than 150 locations in 21 countries. A 3% reduction would come out to about 642 employees laid off. [ABSTRACT FROM AUTHOR]

Gentronix will continue to operate under its current name while expanding its specialist regulatory toxicology services. [ABSTRACT FROM AUTHOR]

French clinical research company Aixial Group is consolidating clinical data from one of its business units into Medidata's digital platform [ABSTRACT FROM AUTHOR]

Clinical MDMA manufacturer PharmAla Biotech is launching an online tool to help scientists easily obtain data needed for clinical trials. [ABSTRACT FROM AUTHOR]

Tom Fleming, a co-founder of Arctoris and formerly chief operating officer, is now the CEO, while Ian Shott becomes chair of the board. [ABSTRACT FROM AUTHOR]

Venture capital in biopharma rose to $9.2 billion across 215 deals in the second quarter of this year—the highest funding level since 2022. [ABSTRACT FROM AUTHOR]

Designing a clinical trial is hard work. Medable hopes to make it easier with their new Medable Studio, an all-in-one eCOA launch application. [ABSTRACT FROM AUTHOR]

Oncology-focused CRO Pi Health has added a new chef to its executive kitchen by appointing Alex Morozov, M.D., Ph.D., as its first CMO. [ABSTRACT FROM AUTHOR]

Global CRO Catalyst Clinical Research is continuing its growth mindset by bringing on board its first ever chief commercial officer, Kristin Judge. [ABSTRACT FROM AUTHOR]

Demand for the company's services is likely to continue its downward trajectory through the rest of the year, according to an August 7 release. [ABSTRACT FROM AUTHOR]

After more than 30 years, gene therapy trailblazer James Wilson M.D., Ph.D., is leaving the University of Pennsylvania to spearhead two new biotechs. [ABSTRACT FROM AUTHOR]

While global incidence of esophageal cancer has increased, so too has the number of clinical trials and potential treatments. [ABSTRACT FROM AUTHOR]

The app records potential trial participants as they watch explanatory videos from researchers, capturing them giving consent. [ABSTRACT FROM AUTHOR]

Just over a month after announcing its new Clinical Data Studio, Medidata has its first big customer: Eisai. [ABSTRACT FROM AUTHOR]

Under the agreement, Charles River will help the Palo Alto accelerator form new academic partnerships. [ABSTRACT FROM AUTHOR]

The risk-reducing union sees insurance underwriter Medical and Commercial International Limited (MCI) pair up with GATC Health Corp. [ABSTRACT FROM AUTHOR]

Private equity dollars are flowing toward clinical trial sites as the industry conditions demand larger site networks, a new PitchBook analysis shows. [ABSTRACT FROM AUTHOR]

Lokavant claims its new AI solution can help contract research organizations and sponsors predict, optimize and control clinical trials in real time. [ABSTRACT FROM AUTHOR]

FDA oncology division director Harpreet Singh, M.D., has left the agency to join Precision for Medicine as chief medical officer. [ABSTRACT FROM AUTHOR]

FDA oncology division director Harpreet Singh, M.D., has left the agency to join Precision for Medicine as chief medical officer. [ABSTRACT FROM AUTHOR]

Flatiron's electronic health record-to-electronic data capture technology for clinical trials will be integrated into the community cancer centers. [ABSTRACT FROM AUTHOR]

The companies have agreed to share resources to help Dt&CRO's clients enter the U.S. pharma market and give Radyus testing services for Asian clients. [ABSTRACT FROM AUTHOR]

American Clinical Research Services has purchased Elixia, a multistate and multispecialty clinical trial network, for an undisclosed sum. [ABSTRACT FROM AUTHOR]

Swiss startup Risklick has launched AI software for clinical trial protocols that it claims can reduce development time and costs by as much as 35%. [ABSTRACT FROM AUTHOR]

Parexel has struck a new deal with Palantir Technologies to integrate its artificial intelligence systems into Parexel's clinical trial operations. [ABSTRACT FROM AUTHOR]

Alcanza Clinical Research's buying spree continues with the acquisition of FDI Clinical Research, a contract research organization in Puerto Rico. [ABSTRACT FROM AUTHOR]

Lindus Health has developed another full-service CRO package for a specific therapeutic area, this time geared toward trials for respiratory diseases. [ABSTRACT FROM AUTHOR]

Clinical health tech company Clario has purchased ArtiQ, a software company that develops AI solutions for diagnosing respiratory diseases. [ABSTRACT FROM AUTHOR]

Headlands Research has opened the fifth and final research site under its partnership with Pfizer to improve trial diversity. [ABSTRACT FROM AUTHOR]

India-based Veeda Clinical Research has acquired Heads, a European CRO with 25 locations in Europe, North America and the Asia Pacific. [ABSTRACT FROM AUTHOR]

Goedde's new role marks expansion of the biometrics services contract research organization's leadership team. [ABSTRACT FROM AUTHOR]

Verified Clinical Trials will integrate its research participation verification tools into ProofPilot's clinical trial automation platform. [ABSTRACT FROM AUTHOR]

TFS HealthScience is going Down Under, setting up a new operational base in Melbourne, Australia. [ABSTRACT FROM AUTHOR]

The buyer, private equity firm Arsenal Capital Partners, will shell out up to $345 million for the companies. [ABSTRACT FROM AUTHOR]

Lindus Health has launched an "all-in-one" CRO for running clinical trials for metabolic disease and diabetes treatments. [ABSTRACT FROM AUTHOR]

NovAliX has partnered with the Max Planck Institute for Multidisciplinary Sciences to translate basic science research into new therapies. [ABSTRACT FROM AUTHOR]

Catawba Research is expanding its leadership team, naming Syed Faridi to serve as vice president of global business development. [ABSTRACT FROM AUTHOR]

Clinical Microbiomics has acquired DNASense ApS, a Danish CRO that's focused on long-read DNA and RNA sequencing technologies. [ABSTRACT FROM AUTHOR]

Medidata has renewed its long-standing contract with Thermo Fisher Scientific's PPD, including their ongoing co-development of PPD TrueCast. [ABSTRACT FROM AUTHOR]

Oncology CRO Sarah Cannon Research Institute, or SCRI, has struck a deal with AstraZeneca to optimize for the company's cancer trials in the U.S. [ABSTRACT FROM AUTHOR]

Medidata has renewed its long-standing contract with Thermo Fisher Scientific's PPD, including their ongoing co-development of PPD TrueCast. [ABSTRACT FROM AUTHOR]

Biopharma is as lean as ever, with pipelines shaved down to stay afloat. What if you could hand off a second-tier asset while maintaining rights? [ABSTRACT FROM AUTHOR]

Charles River Labs will integrate Wheeler's portable chemistry, manufacturing and controls platform into its antibody development process for clients. [ABSTRACT FROM AUTHOR]

The additional space adds room for on-site manufacturing for phase I studies, giving clients the option to pivot doses while studies are in progress. [ABSTRACT FROM AUTHOR]

The U.S.- and Australia-based CRO will use Ryght's large language models to streamline documentation. [ABSTRACT FROM AUTHOR]

The additional space adds room for on-site manufacturing for phase I studies, giving clients the option to pivot doses while studies are in progress. [ABSTRACT FROM AUTHOR]